1) Fekete, L. F., Holst, S. L., Peetoom, F. and Deveber, L. L.: “Auto”-factor IX concentrate: A new therapeutic approach to the treatment of hemophilia A patients with inhibitors. 14th International Congress of Hematology, 1972, San Paulo, Brazil (Abst.).
3) Stenbjerg, S. and Jørgensen, J.: Activated F. IX concentrate (FEIBA) used in the treatment of hemophilic patients with antibody to F. VIII. Acta Med. Scand., 203: 471-476, 1978.
4) Kasper, C. K. and the Hemophilia Study Group: Effect of prothrombin complex concentrates on factor VIII inhibitor levels. Blood, 54: 1358-1368, 1979.
5) Yoshioka, A., Peake, I. R., Furlong, B. L., Furlong, R. A., Giddings, J. C. and Bloom, A. L.: The interaction between factor VIII clotting antigen (VIII CAg) and phospholipid. Brit. J. Haemat., 55: 27-36, 1983.